Using a multidisciplinary team approach, the leadership at Winship Cancer Institute is committed to providing comprehensive programs to treat the whole patient.
Patients know Winship by the excellent care they receive. The fuel that drives this outstanding care is the exhaustive research by top clinicians and researchers from around the world who join forces within Winship. Their discoveries in cancer cell biology, genetics, drugs, radiation, surgery, and other therapies are producing the best treatments available today, and laying the groundwork for treatments of the future. To benefit from these investigational advancements in cancer treatment, it is important to seek care from an academic medical center like Winship, first.
Winship physicians provide care at Emory University Hospital, Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Emory Johns Creek Hospital, Grady Memorial Hospital, the Atlanta VA Medical Center, and Aflac Cancer Center at Children's Healthcare of Atlanta. In addition to using state-of-the-art approaches to cancer therapy, Winship facilitates cancer prevention, treatment, and survivorship through support groups and integrated complementary therapies.
U.S. News & World Report ranks cancer care at Emory University Hospital through Winship in the top 25 cancer programs in the nation. Nurses at Emory University Hospital and Emory Saint Joseph's Hospital have earned the prestigious Magnet recognition for nursing excellence.
Winship investigators conduct more than 250 therapeutic clinical trials and enrolled nearly 800 patients in 2015. Winship has the largest unit in Georgia for phase I clinical trials, which are important to introducing new therapies against cancer. Winship works with the Georgia Center for Oncology Research and Education (GeorgiaCore) to partner with community-based physicians to expand availability of cancer clinical trials throughout Georgia.
Winship is a Lead Academic Participating Site for the NCI National Clinical Trials Network (NCTN). Jonathan Beitler, MD (radiation oncology), Suresh Ramalingam, MD (medical oncology), and Charles Staley, MD (surgical oncology) are co-principal investigators. The NCTN serves as the NCI's primary infrastructure for conducting phase II and III cancer clinical trials, and enrolls over 17,000 patients per year with a variety of cancer types and from diverse backgrounds.
79 Years of Progress
Winship Cancer Institute was founded in 1937, with a generous gift to Emory from Coca-Cola CEO Robert Winship Woodruff, who named the center after his grandfather as a way of honoring his mother who lost her battle to cancer. His mission was that no one would need to leave Georgia for the best cancer treatment. He envisioned doctors and researchers working together in the same facility, so that scientists would be reminded of the urgency of their work and motivated to bring innovative treatments to patients.
Winship treated 168 patients in its first year of operation; now, Winship sees more than 14,000 patients every year. As a patient, you will experience integrative, multidisciplinary care that you could not receive elsewhere in the state. The compassion and dedication of the doctors, nurses and supportive care team are unmatched. Through the discoveries made possible by a dedicated team of many of the nation's best physicians and researchers, Winship works toward a future when science triumphs over cancer.
Courage: Our patients’ exceptional examples of courage inspire our research, our care and our growth as a world-class cancer center.
Compassion: Compassion compels us to do everything humanly possible to reduce the burden that cancer places on our patients.
Collaboration: Winship’s culture of collaboration is built upon trust, communication, and belief in success achieved by working together. We collaborate across disciplines, departments and with external partners in order to achieve a common goal.
Discovery: Winship's enterprising approach to research leads to transformative discoveries. Our faculty, staff, patients, and friends form a strong and vital community committed to pushing the boundaries of imagination and science.
Hope: We work with our patients and their loved ones to establish trust and to communicate a realistic and individualized approach to treatment. In building trust, we gain hope.
Innovation: We value innovation through creativity, discipline, unwavering commitment, and responsibility to our patients. Innovation is realized through the intersection of technology and vision, communication, risk, and belief in the value of our work.
Integrity: We are steadfast in our commitment to Winship patients and their loved ones, to each other, and to our community. We will steward our resources wisely to fulfill our mission.
Winship earned cancer center designation by the National Cancer Institute (NCI) in 2009. What this means to Georgians is improved access to clinical trials and resources available only at designated cancer centers. This designation requires effective collaboration among interdisciplinary teams throughout Emory and other organizations in the Southeast and the United States. These efforts reinforce our commitment to our community and those whom we are privileged to serve.
Winship has 367 faculty members and received $87.4 million in research funding in 2014 with $26.9 million from the NCI.
Winship Cancer Institute is part of Emory’s Woodruff Health Sciences Center, Emory Healthcare and Emory University. Winship offers patients and their family members a vast array of resources in medical oncology, surgical oncology, radiation oncology, diagnostic imaging, complementary therapies, and social services.
Our faculty is comprised of clinicians and researchers within Emory University School of Medicine, Rollins School of Public Health, Nell Hodgson Woodruff School of Nursing, Emory/Georgia Tech Department of Biomedical Engineering, and Emory College.